Chung Chang-Min,Lin Ming-Shyan,Liu Chi-Hung,Lee Tsong-Hai,Chang Shih-Tai,Yang Teng-Yao,Pan Kuo-Li,Lin Yu-Sheng, Discontinuing or continuing statin following intracerebral hemorrhage from the view of a national cohort study, Atherosclerosis, Volume 278, 2018, Pages 15-22.
PubMed link: https://www.ncbi.nlm.nih.gov/pubmed/30236866
Methods | Study design: Retrospective case control study
Number of groups: 2 |
Participants | Number of participants: 2468
Active group: 813 Control: 1655 Age: Mean 67 (± 11.6) Sex: 1299 female (52%) Participants with dementia: 89 Inclusion criteria: · Admission diagnosis intracerebral haemorrhage (ICD-9-CM: 431) · Statin use within the previous 3 months 18-100 years of age Exclusion criteria: Administration of non-statin lipid lowering agents within 3 months prior Death or other loss to follow up within 3 months of haemorrhage Cerebrovascular accident within 3 months of haemorrhage Country: Taiwan Setting: Hospital |
Interventions | Medicine: Statins
Withdrawal schedule: Not described Comparator: Continued statin therapy |
Outcomes | All-cause mortality
Cerebrovascular outcomes (ischemic stroke, recurrent ICH) New onset diabetes, dementia, atrial fibrillation, malignancy, acute hepatitis, rhabdomyolysis, pancreatitis |
Dates | Dates: 01 Jan 2001-31 Dec 2013
Follow-up duration: 36 months |
Funding sources | Chang Gung Memorial Hospital research grant |
Notes |
Risk of bias table
Bias | Authors’ judgment | Support for judgment |
Random sequence generation (selection bias) | Low | Study design |
Allocation concealment (selection bias) | Low | Study design |
Blinding of participants and personnel (performance bias) | Low | Retrospective study |
Blinding of outcome assessment (detection bias) | High | Assessors not blinded |
Incomplete outcome data (attrition bias) | Low | Epidemiological study, used propensity matching for missing data |
Selective reporting (reporting bias) | Low | Study protocol with pre-specified outcomes |
Confounding (non-randomized) | Low | Attempted to match participants with propensity score matching. Multiple confounders reported and included in analysis |
Other bias | ||
Selection bias | Representativeness of the exposed cohort | A: truly representative of the average statin-user post-ICH |
Selection of the non-exposed cohort | B: drawn from the same cohort | |
Ascertainment of exposure | A: secure record | |
Demonstration that outcome of interest was not present at start of study | A: Yes | |
Comparability bias | Comparability of cohorts on the basis of the design or analysis | A: Study controls for statin exposure |
Outcome bias | Assessment of outcome | B: record linkage |
Was follow-up long enough for outcomes to occur | A: yes | |
Adequacy of follow-up of cohorts | A: complete follow-up |
Leave a Reply